New concepts in the pathogenesis of atopic dermatitis

被引：79

作者：

Leung, DYM

Jain, N

Leo, HL

机构：

[1] Univ Colorado, Hlth Sci Ctr, Div Pediat Allergy Immunol, Natl Jewish Med & Res Ctr, Denver, CO USA

[2] Univ Colorado, Hlth Sci Ctr, Dept Pediat, Denver, CO USA

来源：

CURRENT OPINION IN IMMUNOLOGY | 2003年 / 15卷 / 06期

关键词：

D O I：

10.1016/j.coi.2003.09.009

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Atopic dermatitis is a chronic, relapsing, inflammatory skin disease that is characterized by pruritic, eczematoid skin lesions. The disease results from interactions between susceptibility genes, the host environment, skin barrier defects, susceptibility to infection and immunological factors. An increased prevalence of atopic dermatitis has generated increased interest and research into each of these areas, and new treatment strategies are being developed based upon an increased understanding of these issues.

引用

收藏

页码：634 / 638

页数：5

相关论文

共 46 条

[1] T helper (Th) 2 predominance in atopic diseases is due to preferential apoptosis of circulating memory/effector Th1 cells [J].

Akdis, M ;

Trautmann, A ;

Klunker, S ;

Daigle, I ;

Küçüksezer, UC ;

Deglmann, W ;

Disch, R ;

Blaser, K ;

Akdis, CA .

FASEB JOURNAL, 2003, 17 (09) :1026-1035

[2] Perforin hyperreleasability and depletion in cytotoxic T cells from patients with exacerbated atopic dermatitis and asymptomatic rhinoconjunctivitis allergica [J].

Ambach, A ;

Bonnekoh, B ;

Gollnick, H .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (05) :878-886

[3] Atopic dermatitis is associated with a low-producer transforming growth factor β1 cytokine genotype [J].

Arkwright, PD ;

Chase, JM ;

Babbage, S ;

Pravica, V ;

David, TJ ;

Hutchinson, IV .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 108 (02) :281-+

[4]

Boguniewicz M, 2001, J ALLERGY CLIN IMMUN, V108, P651, DOI 10.1067/mai.2001.118598

[5] Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin [J].

Cho, SH ;

Strickland, I ;

Boguniewicz, M ;

Leung, DYM .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 108 (02) :269-274

[6] The genetics of atopic dermatitis [J].

Cookson, William O. C. M. ;

Moffatt, Miriam F. .

CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 2 (05) :383-387

[7] Smallpox vaccination: Risk considerations for patients with atopic dermatitis [J].

Engler, RJM ;

Kenner, J ;

Leung, DYM .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 110 (03) :357-365

[8] Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines [J].

Giustizieri, ML ;

Mascia, F ;

Frezzolini, A ;

De Pità, O ;

Chinni, LM ;

Giannetti, A ;

Girolomoni, G ;

Pastore, S .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (05) :871-877

[9] Assessment of epidermal barrier function by photoacoustic spectrometry in relation to its importance in the pathogenesis of atopic dermatitis [J].

Hata, M ;

Tokura, Y ;

Takigawa, M ;

Sato, M ;

Shioya, Y ;

Fujikura, Y ;

Imokawa, G .

LABORATORY INVESTIGATION, 2002, 82 (11) :1451-1461

[10] Tacrolimus (FK506): New treatment approach in superantigen-associated diseases like atopic dermatitis? [J].

Hauk, PJ ;

Leung, DYM .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (02) :391-392

← 1 2 3 4 5 →